The Cigna Group announced the pricing terms of its previously announced offers to purchase for cash any and all of The Cigna Group’s 3.50% Senior Notes...
AZmed has secured €15 million in Series A funding. The operation includes investors such as Maison Worms, Techstars, and Tempact Ventures. The investment supports AZmed’s overarching...
MIP Discovery announced it has closed a £7 million GBP (~$9 million USD) Series A financing round, led by Mercia Ventures. Existing investor Calculus Capital also...
HealthStream, Inc. announced results for the fourth quarter and full-year ended December 31, 2023. Fourth quarter 2023 Revenues of $70.6 million, up 3% from $68.5 million...
CMR Surgical announces that Sushobhan Dasgupta has joined the Company as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa. Sushobhan brings...
AtriCure, Inc. announced fourth quarter 2023 and full year 2023 financial results. “Our 2023 results showcase the broad-based expansion of our many growth drivers, balanced by...
10x Genomics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023 and provided outlook for 2024. “Our innovation engine has...
TransMedics Group, Inc. announced that it granted non-qualified stock options to purchase an aggregate of 4,041 shares of its common stock and an aggregate of 2,627...
Delcath Systems, Inc. announced that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as a material inducement to the employment of three...
Lifecore Biomedical, Inc. announced that on February 13, 2024 it received a Staff Delisting Determination from the Listing Qualifications Department of The Nasdaq Stock Market LLC...
Iovance Biotherapeutics, Inc. announced that on February 15, 2024, the Company approved the grant of inducement stock options covering an aggregate of 40,450 shares of Iovance’s...
Cue Health announced it entered into a cooperation agreement with Tarsadia Investments, and appointed Rishi Reddy to its board of directors (the “Board”), effective immediately. Reddy...
Larimar Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 19,736,842 shares of its common stock, which includes the exercise in full...
Freenome announced the addition of $254 million from new and existing investors. The funding enables Freenome to advance the pipeline of single-cancer and tailored multi-cancer early...
Global health company The Cigna Group will repurchase $3.2 billion of common stock through accelerated stock repurchase agreements with Deutsche Bank AG and Bank of America,...
Copyright © 2024 Medical Buyer